- Home
- ABVE vs NERV Comparison
ABVE vs NERV Comparison
Compare ABVE & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVE
- NERV
- Stock Information
- Founded
- ABVE 2019
- NERV 2007
- Country
- ABVE Canada
- NERV United States
- Employees
- ABVE N/A
- NERV N/A
- Industry
- ABVE Packaged Foods
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ABVE Consumer Staples
- NERV Health Care
- Exchange
- ABVE Nasdaq
- NERV Nasdaq
- Market Cap
- ABVE 15.1M
- NERV 16.0M
- IPO Year
- ABVE N/A
- NERV 2014
- Fundamental
- Price
- ABVE $0.49
- NERV $2.30
- Analyst Decision
- ABVE
- NERV Hold
- Analyst Count
- ABVE 0
- NERV 1
- Target Price
- ABVE N/A
- NERV $5.00
- AVG Volume (30 Days)
- ABVE 577.5K
- NERV 55.2K
- Earning Date
- ABVE 02-15-2025
- NERV 02-20-2025
- Dividend Yield
- ABVE N/A
- NERV N/A
- EPS Growth
- ABVE N/A
- NERV N/A
- EPS
- ABVE N/A
- NERV N/A
- Revenue
- ABVE $275,376,450.00
- NERV N/A
- Revenue This Year
- ABVE N/A
- NERV N/A
- Revenue Next Year
- ABVE N/A
- NERV N/A
- P/E Ratio
- ABVE N/A
- NERV N/A
- Revenue Growth
- ABVE N/A
- NERV N/A
- 52 Week Low
- ABVE $0.34
- NERV $2.03
- 52 Week High
- ABVE $4.07
- NERV $13.49
- Technical
- Relative Strength Index (RSI)
- ABVE N/A
- NERV 48.97
- Support Level
- ABVE N/A
- NERV $2.27
- Resistance Level
- ABVE N/A
- NERV $2.69
- Average True Range (ATR)
- ABVE 0.00
- NERV 0.17
- MACD
- ABVE 0.00
- NERV 0.01
- Stochastic Oscillator
- ABVE 0.00
- NERV 34.09
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.